Perflenapent
Names | |
---|---|
IUPAC name
Dodecafluoropentane | |
Other names
Perfluoropentane | |
Identifiers | |
678-26-2 | |
ChemSpider | 12154 |
Jmol interactive 3D | Image |
PubChem | 12675 |
| |
| |
Properties | |
C5F12 | |
Molar mass | 288.04 g·mol−1 |
Density | 1.63 g/mLl (liquid, 25 °C) [1] 1.59 g/ml (liquid, 35 °C) |
Melting point | −115 °C (−175 °F; 158 K) |
Boiling point | 28 °C (82 °F; 301 K) |
Vapor pressure | 83.99 kPa (25 °C) |
Viscosity | 0.652 mPa*s (25 °C) |
Thermochemistry | |
0.26 cal/(g • K) | |
Pharmacology | |
ATC code | V08 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Perflenapent (INN/USAN), or perfluoropentane (PFP), is a fluorocarbon. It has several biomedical applications including: propellant for pressurized metered dose inhalers;[2] gas core in microbubble ultrasound contrast agents;[3] and occlusion therapy via the conversion of nanometer liquid droplets into micrometer sized gas microbubbles (acoustic droplet vaporization).[4]
References
- ↑ "Perfluoropentane". Retrieved January 14, 2013.
- ↑ Rogueda, P. G. A. HPFP, a Model Propellant for pMDIs. Drug Dev. Ind. Phar. 2003, 29, 39
- ↑ Liu, Y., Miyoshi, H., and Nakamura, M. Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery. J. Controlled Release 2006, 114, 89− 99
- ↑ D. Bardin, T. D. Martz, P. S. Sheeran, R. Shih, P. A. Dayton, and A. P. Lee, “High-speed, clinical-scale microfluidic generation of stable phase-change droplets for gas embolotherapy,” Lab on a Chip, vol. 11, no. 23, p. 3990, 2011.
|
This article is issued from Wikipedia - version of the Monday, March 07, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.